Please login to the form below

Not currently logged in
Email:
Password:

Sudler London makes three senior hires

Mark Boulding, Jason Galla-Barth and Abbie Pound will boost its London office

Sudler London Mark Boulding Jason Galla-Barth Abbie PoundSudler & Hennessey Group UK has appointed Mark Boulding as director of strategy, Jason Galla-Barth as head of digital and Abbie Pound as head of medical communications. 

Boulding joins with more than 25 years of experience in the pharma industry, having worked in sales and marketing prior to moving into senior client roles in healthcare advertising agencies. 

Galla-Barth has worked for 20 years across numerous market sectors, including TV, press, radio and digital communications. 

Pound, too, has significant medical communications and education experience, having formerly served as senior editor of The Lancet and director of quality at Succinct Medical Communications.

David Higgins, UK managing director at Sudler & Hennessey, said: “I am very excited to bring in such experienced and proven leaders to our team in London. This very much supports our overall vision to be able to offer our clients truly integrated and connected communication in healthcare.”

20th August 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics